Top News
The Drug Enforcement Administration extends telehealth flexibility in the prescribing of controlled substances through December 31, 2026.
This fourth extension came during the last hours of December 31 and took effect…
What You Should Know:
– In a significant move for the “tele-prescribing” landscape, the U.S. Department of Health and Human Services (HHS) and the Drug Enforcement Administration (DEA) have announced a fourth temporary extension of…
Continue Reading
DEA, HHS extend telemedicine flexibilities for remote prescribing of controlled substances | MobiHealthNews
Skip to main content…
Continue Reading
Hot off the presses, the new Oracle Health EHR has received certification for ambulatory use and approval for electronic prescribing of controlled substances.
Oracle claims that the EHR was built independently of the original…
What You Should Know:
– Oracle Health has announced a major breakthrough with its next-generation Electronic Health Record (EHR), which is now certified and available for adoption by ambulatory customers in the U.S..
– The new…
Continue Reading
What You Should Know:
– Despite increased investments in detection programs, drug diversion—the illegal obtaining of prescription drugs by healthcare staff—continues to be a significant and often underreported issue within U.S. hospitals and health systems,…
Continue Reading
Healthcare Groups Challenge Proposed Regulations
Healthcare provider organizations are mounting significant opposition to the Drug Enforcement Administration’s (DEA) proposed special registration framework for telehealth prescribing of controlled substances. Both the American Hospital Association (AHA) and…
The U.S. Drug Enforcement Administration has proposed draft guidance to establish a framework for prescribing controlled substances via telemedicine.The proposal introduces three types of special registrations. Telemedicine prescribing registration allows qualified practitioners to prescribe…
Continue Reading
The U.S. Drug Enforcement Agency’s proposed rule to establish special registrations for providers and telemedicine platforms to prescribe certain schedules of controlled substances without requiring an in-person doctor’s visit requires “meaningful” clarification and adjustments,…
Continue Reading
For about half a decade now, Americans have had the ability to receive controlled substances via telehealth because requirements were relaxed during the Covid-19 pandemic. This has greatly expanded access particularly for those in…
Continue Reading
